Friday, August 17, 2018
 
 
Company News: Page (1) of 1 - 08/08/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Landauer, Inc. Reports Fiscal 2017 Third Quarter Results - Earnings Per Diluted Share Of $0.66
 
(August 08, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Pro AV,Post/Production,Management,Presentors,Management,Internet/Web,Business,Internet,Webcasting,Law,Standards/Initiatives,Business Issues,Internet Media,Presentation,Channel/Distribution,Events, webcast, Inc.,Science,Internet Technology,Physics,Business,Internet,Other,
Related Sites: Digital Producer ,   Digital Webcast ,   Digital Post Production ,   Presentation Master ,   Oceania ,   DMN Newswire ,   BN - Webcast ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: DMN Newsletter ,   CMN Newsletter ,   Streamline Newsletter ,   KNews Newsletter ,   Digital Media Net ,   DMNForums ,   Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines